Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | Child Neurology and Developmental Neurology Posters

This program spans the entire conference
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Child Neurology and Developmental Neurology
0.00 credit
COVID-19

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT Abstract 001 - Impacts of COVID-19 Related Shelter-in-Place Mandates on Hospital-Based Care for Pediatric Neurological Diagnoses
Melissa Hutchinson, MD
07:00 AM - 05:00 PM EDT Abstract 002 - Variability in Pediatric Brain Death Protocols in the United States
Matthew Kirschen, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 003 - Prognosticating Factors for Pediatric Concussion
Mark Andrews
07:00 AM - 05:00 PM EDT Abstract 004 - Pediatric Ischemic Stroke Receiving IV tPA: a Case Series
Sama Astani, MD
07:00 AM - 05:00 PM EDT Abstract 005 - Dissociation Between Clinical Outcome and Electrographic Features in a Case of Extended Release Bupropion Overdose
Nita Chen, MD
07:00 AM - 05:00 PM EDT Abstract 006 - An Atypical Case of Pediatric Spinal Cord Ischemia After Jejunojejunostomy
Meghan M. Branston, MD
07:00 AM - 05:00 PM EDT Abstract 007 - Alice in Wonderland Syndrome With Pediatric Concussion and Synesthesia: A Unique Occurrence
Geetha Vasudevan, MD
07:00 AM - 05:00 PM EDT Abstract 008 - Transient Prenatal Hypoxia Leads to Deficits in Juvenile Neuronal Morphology and Neonatal Behaviors
Elyse Gadra
07:00 AM - 05:00 PM EDT Abstract 009 - Prognostic Accuracy of Fetal MRI in Predicting Postnatal Neurodevelopmental Outcome
Mitchell Wilson, MD
07:00 AM - 05:00 PM EDT Abstract 010 - RGX-121 gene therapy for severe Mucopolysaccharidosis Type II (MPS II): Interim neurodevelopmental outcomes and biomarker results
Paul Harmatz
07:00 AM - 05:00 PM EDT Abstract 011 - Efficacy of a Pediatric Headache Infusion Center in Reducing Emergency Room Visits and Cost of Care
Asia Payne, MD
07:00 AM - 05:00 PM EDT Abstract 012 - Neurophysiological Findings of Visual Evoked Potentials in Children Diagnosed With Type 1 Diabetes
07:00 AM - 05:00 PM EDT Abstract 013 - Effects of age, sex, and concussion history on pattern reversal visual evoked potentials in children
Carlyn Patterson Gentile, MD
07:00 AM - 05:00 PM EDT Abstract 014 - Use of Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Pediatric Migraine Prevention
Saher Suleman, MD
07:00 AM - 05:00 PM EDT Abstract 016 - Reduced Metabotropic Glutamate Receptor Subtype 5 in Fragile X Syndrome
James R. Brasic, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 017 - Deficits in Tonic Inhibition May Contribute to Motor and Behavioral Abnormalities in Angelman Syndrome and Fragile X Syndrome
Tom Parry
07:00 AM - 05:00 PM EDT Abstract 018 - Integrated deep phenotypic and mutational approach defines EBF3-related HADD syndrome genotype-phenotype relationships
Cole A. Deisseroth
07:00 AM - 05:00 PM EDT Abstract 019 - Scaffolding the Attention-Deficit/Hyperactivity Disorder Brain Using Random Noise Stimulation: A Randomized Controlled Trial
Itai Berger, MD
07:00 AM - 05:00 PM EDT Abstract 020 - Time to retreatment following abobotulinumtoxinA injections in children with upper-limb spasticity
Ann H. Tilton, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 021 - Deep phenotyping reveals patients with SYNGAP1 mutations have a multi-domain neurological disorder
Jimmy Holder, MD
07:00 AM - 05:00 PM EDT Abstract 022 - Dose-Regimen Findings for OV101 (Gaboxadol) in Clinical Studies of Angelman Syndrome and Fragile X Syndrome and Implications for Treatment
Elizabeth M. Berry-Kravis, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 023 - Association Between Humidifier Disinfectant Exposure During Infancy and Subsequent Neuropsychiatric Outcomes During Childhood
Sihyeong Park, MD
07:00 AM - 05:00 PM EDT Abstract 024 - Effects of sara rosenfeld johnson’s oral motor exercises on drooling in children with cerebral palsy
07:00 AM - 05:00 PM EDT Abstract 025 - Effects of Low Frequency Repetitive Transcranial Magnetic Stimulation Combined with Language Training on Language Disorder in Children with Cerebral Palsy
07:00 AM - 05:00 PM EDT Abstract 026 - HD-EEG spectra in 6-year-old children born prematurely
Courtney Nguyen
07:00 AM - 05:00 PM EDT Abstract 027 - A case of Bainbridge-Ropers syndrome with breath holding spells: challenges in diagnosis and management.
Tuba Rashid Khan, MD
07:00 AM - 05:00 PM EDT Abstract 028 - Disease Stabilization Following Treatment with elivaldogene autotemcel (eli-cel, Lenti-D) Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy: Interim Results from Phase 2/3 (ALD-102) and Phase 3 (ALD-104) Studies
Florian Eichler, MD
07:00 AM - 05:00 PM EDT Abstract 029 - Clinico-genetic Profile and Treatment Outcomes of Inherited Hypermanganesemia in Indian Children: A Multi-centric Study
Divyani Garg, MD, FRCP
07:00 AM - 05:00 PM EDT Abstract 030 - Bi-allelic loss-of-function variants in the splicing regulator NSRP1 cause a severe neurodevelopmental disorder with epilepsy
Daniel Calame, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 031 - Bi-allelic variants in the ectonucleotidase ENTPD1 cause a complex neurological disease consisting of intellectual disability, brain abnormalities, and spastic paraplegia
Daniel Calame, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 032 - De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects
Stephanie Efthymiou
07:00 AM - 05:00 PM EDT Abstract 033 - Natural History Study of SURF-1
Tuba Rashid Khan, MD
07:00 AM - 05:00 PM EDT Abstract 034 - Improved Motor Function in Children With Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Treated With Eladocagene Exuparvovec (PTC-AADC): Interim Findings From a Phase 1/2 Study
Mark Pykett
07:00 AM - 05:00 PM EDT Abstract 035 - Epidemiology and Access to Expert Care for the Neuronal Ceroid Lipofuscinoses (NCL)
Margaux C. Masten, Undergraduate
07:00 AM - 05:00 PM EDT Abstract 036 - Neuronal Ceroid Lipofuscinosis Assessment Utilizing Virtual Visits During a Pandemic
Amy Vierhile, NP, DNP
07:00 AM - 05:00 PM EDT Abstract 037 - Diagnostic Confidence for CLN3 Disease (Juvenile Batten Disease)
Margaux C. Masten, Undergraduate
07:00 AM - 05:00 PM EDT Abstract 038 - Visual Evoked Potentials Findings In Children Diagnosed With Neurofibromatosis Type 1
07:00 AM - 05:00 PM EDT Abstract 039 - Genotype and symptom prevalence in TANGO2 disease: In-frame pathogenic variants affecting the proximal amino region of the TANGO2 protein correlate with a mitochondrial phenotype
Samuel J. Mackenzie, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 040 - Clinical Characteristics of Patients with Cardiofaciocutaneous Syndrome
Carmen A. Aguirre
07:00 AM - 05:00 PM EDT Abstract 041 - Improved Motor Function in Children With Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Treated With Eladocagene Exuparvovec (PTC-AADC): Compassionate Use Study
Mark Pykett
07:00 AM - 05:00 PM EDT Abstract 042 - Improved Motor Function in Children With Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Treated With Eladocagene Exuparvovec (PTC-AADC): Interim Findings From a Phase 2 Trial
Mark Pykett
07:00 AM - 05:00 PM EDT Abstract 043 - The Rarest of The Rare: Late-Onset Pyridoxine Dependent Epilepsy in a Child
Barbra Giourgas, MD
07:00 AM - 05:00 PM EDT Abstract 044 - A phase I/II open-label gene replacement clinical study for late onset Pompe disease
Tahseen Mozaffar, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 045 - A de novo heterozygous rare variant in SV2A predisposes to epilepsy and levetiracetam-induced refractory status epilepticus
Isabella Herman, MD
07:00 AM - 05:00 PM EDT Abstract 046 - Multilocus pathogenic variation in ZC4H2, MUSK, CAPN3, and NAV2 results in a blended phenotype of severe neurodevelopmental disorder with epilepsy, brain malformation, hypotonia, dysmorphism, and musculoskeletal abnormalities
Isabella Herman, MD
07:00 AM - 05:00 PM EDT Abstract 047 - Dancing Diabetes: A rare pediatric case of non-ketotic hyperglycemic hemichorea-hemiballismus
Allie C. Toth, MD
07:00 AM - 05:00 PM EDT Abstract 048 - Case Report of BRAT1-associated Lethal Neonatal Rigidity and Multifocal Seizure Syndrome
Donya Eizadkhah, MD
07:00 AM - 05:00 PM EDT Abstract 049 - Pitt Hopkins-Like Syndrome 1 with novel CNTNAP2 mutation in siblings
Rea Mittal, MD
07:00 AM - 05:00 PM EDT Abstract 050 - An Adult Case of Non-Ketotic Hyperglycinemia Due to Novel Compound Heterozygous Variants in GLDC
Andrew Dhawan, MD
07:00 AM - 05:00 PM EDT Abstract 051 - A novel homozygous IBA57 (p.Gly104Cys) variant associated with a rapidly progressive neurodegenerative disease in infancy: a case report.
Franklyn Rocha Cabrero, MD
07:00 AM - 05:00 PM EDT Abstract 052 - Longitudinal Cognitive Outcomes in Children with Human Immunodeficiency Virus in Zambia
Gauri Patil, MD
07:00 AM - 05:00 PM EDT Abstract 053 - Post-COVID-19 Acute Disseminated Encephalomyelitis in a 17-month-old
Loren A. McLendon, MD
07:00 AM - 05:00 PM EDT Abstract 054 - Impact of the COVID-19 Pandemic on Mental Health, Physical Activity and Sleep in Children with Neuroinflammatory Disorders
Lindsey Vogt, MD
07:00 AM - 05:00 PM EDT Abstract 055 - Guideline for the Assessment and Treatment of Pain in Children with Multiple Sclerosis (MS): A Delphi Panel
Catherine Stratton, MPH
07:00 AM - 05:00 PM EDT Abstract 056 - Primary Infections, a Trigger for Myelin Oligodendrocyte Glycoprotein (MOG) Encephalomyelitis?
Nusrat Ahsan, MD
07:00 AM - 05:00 PM EDT Abstract 057 - Predictive Value of Consensus Criteria for the Early Detection of Pediatric Autoimmune Encephalitis
Tiffany Pointon, MD
07:00 AM - 05:00 PM EDT Abstract 058 - A Rare Combination: Pediatric Case Report of Kabuki Syndrome and CASPR-2 Autoimmune Encephalitis
Veronica Gaffney, DO
07:00 AM - 05:00 PM EDT Abstract 059 - Onasemnogene Abeparvovec Gene Therapy in Presymptomatic Spinal Muscular Atrophy (SMA): SPR1NT Study Update in Children with 2 Copies of SMN2
Kevin Strauss
07:00 AM - 05:00 PM EDT Abstract 060 - SUNFISH Part 2: 24-month Efficacy and Safety of Risdiplam in Patients with Type 2 or Non-ambulant Type 3 Spinal Muscular Atrophy (SMA)
Maryam Oskoui, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 061 - Six Month Results of Spinraza in Adults with Spinal Muscular Atrophy (SAS) Study
Craig M. Zaidman, MD
07:00 AM - 05:00 PM EDT Abstract 062 - FIREFISH Part 2: 24-month Efficacy and Safety of Risdiplam in Infants with Type 1 Spinal Muscular Atrophy (SMA)
Basil T. Darras, MD
07:00 AM - 05:00 PM EDT Abstract 063 - The Role of the Signal Recognition Particle in Motor Neuron Development and Implications for SMA
Nikaela Losievski
07:00 AM - 05:00 PM EDT Abstract 064 - JEWELFISH: Safety and Pharmacodynamic Data in Non-Naïve Patients with Spinal Muscular Atrophy (SMA) Receiving Treatment with Risdiplam
Claudia A. Chiriboga, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 065 - Diagnostic Odyssey for Patients with FKRP-associated Muscular Dystrophy
Lauren Coffey
07:00 AM - 05:00 PM EDT Abstract 066 - Characterising the Influence of Dystrophin Brain Isoform Involvement on the Pattern of Motor Impairment in Duchenne Muscular Dystrophy
Mary Chesshyre, MBBS
07:00 AM - 05:00 PM EDT Abstract 067 - Pooled Safety Data from the Risdiplam Clinical Trial Development Program
Laurent Servais
07:00 AM - 05:00 PM EDT Abstract 068 - Results of 2019 Study on Clinical Trial Experiences of SMA Patients and Families
Ilse Peterson
07:00 AM - 05:00 PM EDT Abstract 069 - Outcomes of Single-Agent Onasemnogene Abeparvovec or Nusinersen, and of Nusinersen Switching to Onasemnogene Abeparvovec, in Patients With Spinal Muscular Atrophy: Results of a Provider Survey in the United States
Omar Dabbous
07:00 AM - 05:00 PM EDT Abstract 070 - Real-World Reasons for Steroid Switching and Associated Clinical Outcomes Among Patients with Dystrophinopathies in the US: a Nationwide Review of Medical Records
07:00 AM - 05:00 PM EDT Abstract 071 - Assessment of current best-practices, across neurology and SMA care centers in the US, to triage and expedite incoming referrals for the evaluation of Spinal Muscular Atrophy
Mary Curry, ND
07:00 AM - 05:00 PM EDT Abstract 072 - Ataluren Delays Loss of Ambulation and Decline in Pulmonary Function in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
Panayiota Trifillis
07:00 AM - 05:00 PM EDT Abstract 073 - Small Fiber Neuropathy (SFN) Causes Autonomic Dysfunction and/or Pain/Sensory Dysfunction in Children
Vikram Prakash, MD
07:00 AM - 05:00 PM EDT Abstract 074 - Nusinersen Dosing Patterns in Patients With Spinal Muscular Atrophy Type 1 in the United States: Findings From a Retrospective Claims Database Analysis
07:00 AM - 05:00 PM EDT Abstract 075 - Acute Descending Paralysis and Respiratory Distress: Myasthenia Gravis vs Wound Botulism
Adam C. Kneepkens
07:00 AM - 05:00 PM EDT Abstract 076 - RAINBOWFISH: A Study of Risdiplam in Newborns with Presymptomatic Spinal Muscular Atrophy (SMA)
Richard S. Finkel, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 077 - Real-World Patterns of Nusinersen Use in Adult Patients with Spinal Muscular Atrophy (SMA) in the US: A Multi-Site Chart Review Study
Lauren B. Elman, MD
07:00 AM - 05:00 PM EDT Abstract 078 - Pediatric Small-Fiber Neuropathy: Towards a Case Definition
Madeleine Klein, BS
07:00 AM - 05:00 PM EDT Abstract 079 - Use of MLPA for the diagnosis of Duchenne Muscular Dystrophy: Systematic Review and Meta-Analysis
Marco M. Malaga, MD
07:00 AM - 05:00 PM EDT Abstract 080 - Escalating Dose and Randomized, Controlled Study of Nusinersen in Participants With Spinal Muscular Atrophy (SMA); Study Design and Part A Data for the Phase 2/3 DEVOTE (232SM203) Study to Explore High Dose Nusinersen
John W. Day, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 081 - Research-to-Clinical Results of Trio Exome Sequencing in a Large, Single-Center Epilepsy Cohort
Hyunyong Koh, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 082 - Clinical Spectrum and Comorbidities among Children with West Syndrome with Drug Refractory Epilepsy
Nitya Beriwal, MBBS
07:00 AM - 05:00 PM EDT Abstract 083 - Adrenal Insufficiency among Children treated with Hormonal Therapy for Infantile Spasms
Gabrielle Doré-Brabant
07:00 AM - 05:00 PM EDT Abstract 084 - Etiology of Infantile Spasms And Yield of Genetic Testing : A Tertiary Center Study
Nitish Chourasia, MD
07:00 AM - 05:00 PM EDT Abstract 085 - Improving Medication Non-Adherence Screening and Provider Interventions for Children with Epilepsy
Jaclyn Tencer, MD
07:00 AM - 05:00 PM EDT Abstract 086 - Ketogenic Diet in Trisomy 21 Patients with Refractory Epilepsy
Joanna I. Garcia Pierce, MD
07:00 AM - 05:00 PM EDT Abstract 087 - Pediatric Neurologists’ Knowledge, Attitudes, and Practices Regarding Sexual and Reproductive Healthcare for Adolescent and Young Adult Women with Epilepsy
Laura A. Kirkpatrick, MD
07:00 AM - 05:00 PM EDT Abstract 088 - Length of Stay Linked to Neurodiagnostic Workup for Seizures Presenting to the Pediatric Emergency Department
Maria El-Hallal, MD
07:00 AM - 05:00 PM EDT Abstract 089 - First Reported Case of a Paternally-inherited CHD2-related Lennox-Gastaut Syndrome with Spontaneous Clinical Seizure Resolution
Danielle A. Reynolds, MD
07:00 AM - 05:00 PM EDT Abstract 090 - Assessment of adrenal function after ACTH treatment in children with infantile spasms: a retrospective analysis of local practices and trends
Babitha Haridas, MBBS
Faculty Disclosures
No disclosure on file
Danielle A. Reynolds, MD Dr. Reynolds has nothing to disclose.
Franklyn Rocha Cabrero, MD Dr. Rocha Cabrero has nothing to disclose.
Alexander Kolevzon Alexander Kolevzon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ovid Therapeutics. Alexander Kolevzon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Alexander Kolevzon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Therapeutics. Alexander Kolevzon has received stock or an ownership interest from Ovid Therapeutics. The institution of Alexander Kolevzon has received research support from AMO Pharma. Alexander Kolevzon has received publishing royalties from a publication relating to health care.
Jena M. Krueger, MD Dr. Krueger has nothing to disclose.
Hyunyong Koh, MD, PhD Dr. Koh has nothing to disclose.
Wendy S. Vargas, MD Dr. Vargas has received personal compensation for serving as an employee of Sanofi.
Giovanni Baranello Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AveXis. The institution of Giovanni Baranello has received research support from Great Ormond Street Hospital Charity.
Dmitry Vlodavets No disclosure on file
Pelekelo Kabundula Pelekelo Kabundula has nothing to disclose.
Sarah R. Risen, MD Dr. Risen has nothing to disclose.
Ayon Nandi No disclosure on file
Traci Kazmerski The institution of Traci Kazmerski has received research support from Cystic Fibrosis Foundation. The institution of Traci Kazmerski has received research support from NIH.
Leslie Nelson No disclosure on file
Chethan K. Rao, DO Dr. Rao has nothing to disclose.
Veronica Gaffney, DO No disclosure on file
Martin Cloutier, MD No disclosure on file
Gogi Kumar, MD Dr. Kumar has nothing to disclose.
Nicholas Deconinck Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Nicholas Deconinck has received publishing royalties from a publication relating to health care.
Elizabeth M. Berry-Kravis, MD, PhD The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Zevra. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren.
Christina Master, MD, FAAP, CAQSM The institution of Dr. Master has received research support from NIH. The institution of Dr. Master has received research support from DoD. The institution of Dr. Master has received research support from AMSSM. The institution of Dr. Master has received research support from PA Department of Health. Dr. Master has received intellectual property interests from a discovery or technology relating to health care. Dr. Master has received intellectual property interests from a discovery or technology relating to health care. Dr. Master has received intellectual property interests from a discovery or technology relating to health care.
Mustafa Sahin, MD, PhD Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenxbio . Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Centene. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for PTEN Research. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Sahin has received research support from NIH. The institution of Dr. Sahin has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sahin has received research support from Charities Aid Foundation. The institution of Dr. Sahin has received research support from Simons Foundation Autism Research Initiative. The institution of Dr. Sahin has received research support from Aucta Pharmaceuticals . The institution of Dr. Sahin has received research support from Loulou Foundation.
Elizabeth M. Wells, MD The institution of Dr. Wells has received research support from National Institute of Allergy and Infectious Diseases.
Yoshimi Sogawa, MD Dr. Sogawa has nothing to disclose.
Sihyeong Park, MD Dr. Park has nothing to disclose.
Craig M. Zaidman, MD Dr. Zaidman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sarepta. The institution of Dr. Zaidman has received research support from Washington University in St Louis. The institution of Dr. Zaidman has received research support from Novartis.
Heather Gordish-Dressman Heather Gordish-Dressman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AGADA Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TRiNDS, LLC. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Statistical reviewer with TREAT-NMD TACT Committee.
Gauri Patil, MD Ms. Patil has nothing to disclose.
Carlos Alva-Diaz Carlos Alva-Diaz has nothing to disclose.
Mark P. Fitzgerald, MD, PhD Dr. Fitzgerald has nothing to disclose.
Vykuntaraju Gowda, DM Prof. Gowda has nothing to disclose.
Tiffany Pointon, MD Dr. Pointon has nothing to disclose.
Kartik Iyer No disclosure on file
Constance Smith-Hicks, MD, PhD The institution of Dr. Smith-Hicks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PaxMedica.
Geetha Vasudevan, MD Geetha Vasudevan has nothing to disclose.
Kendall Nash, MD Dr. Nash has nothing to disclose.
Divyani Garg, MD, FRCP Dr. Garg has nothing to disclose.
Isabella Herman, MD Dr. Herman has nothing to disclose.
Danah Marafie, MD Dr. Marafie has received research support from United States National Institute of Health.
Alison M. Dolce, MD Dr. Dolce has nothing to disclose.
Darryl C. De Vivo, MD, FÂ鶹´«Ã½Ó³»­ Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Jennifer M. Kwon, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kwon has nothing to disclose.
Heather E. Olson, MD Dr. Olson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda pharmaceuticals. The institution of Dr. Olson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ovid Therapeutics. The institution of Dr. Olson has received research support from NINDS. The institution of Dr. Olson has received research support from International Foundation for CDKL5 Research. The institution of Dr. Olson has received research support from Marinus Pharmaceuticals. The institution of Dr. Olson has received research support from Ovid Therapeutics.
Maria Mazurkiewicz-Beldzin Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen, . Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Mohammad A. Al-Muhaizea, MD Dr. Al-Muhaizea has nothing to disclose.
Ermal Aliu No disclosure on file
Elizabeth D. McNeil No disclosure on file
James J. Riviello, Jr., MD Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for J. Kiffin Penry Foundation. An immediate family member of Dr. Riviello has received publishing royalties from a publication relating to health care. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Utah. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Calgary.
Gabriela Purcarin, MD Dr. Purcarin has nothing to disclose.
Nathalie M. Goemans, MD Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Goemans has received publishing royalties from a publication relating to health care.
Mary K. Schroth, MD Dr. Schroth has received personal compensation for serving as an employee of Cure SMA. The institution of Dr. Schroth has received research support from Biogen.
Janbernd Kirschner No disclosure on file
Lauren Coffey Lauren Coffey has nothing to disclose.
Marco M. Malaga, MD Mr. Malaga has nothing to disclose.
Andrew Dhawan, MD Dr. Dhawan has nothing to disclose.
Maryam Oskoui, MD, FÂ鶹´«Ã½Ó³»­ Dr. Oskoui has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for the Association des Neurologues du Quebec. The institution of Dr. Oskoui has received research support from Hoffmann-La Roche Ltd. The institution of Dr. Oskoui has received research support from Muscular Dystrophy Canada. The institution of Dr. Oskoui has received research support from Canadian Institutes of Health Research. The institution of Dr. Oskoui has received research support from Santhera. The institution of Dr. Oskoui has received research support from Novartis. The institution of Dr. Oskoui has received research support from Fonds de Recherche du Québec. Dr. Oskoui has a non-compensated relationship as a Member of the Medical and Scientific Advisory Committee with Muscular Dystrophy Canada that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Jaclyn Tencer, MD Dr. Tencer has nothing to disclose.
Maria El-Hallal, MD Dr. El-Hallal has nothing to disclose.
Senda Ajroud-Driss, MD, FÂ鶹´«Ã½Ó³»­ Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astrazeneca. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Ajroud-Driss has received research support from NIH. The institution of Dr. Ajroud-Driss has received research support from University of Minesota/FDA. The institution of Dr. Ajroud-Driss has received research support from Edgewise Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Biogen. The institution of Dr. Ajroud-Driss has received research support from Woolsey Pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Uniqure Biopharma. The institution of Dr. Ajroud-Driss has received research support from Coya Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Novartis. The institution of Dr. Ajroud-Driss has received research support from Alnylam pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Healey and AMG center for ALS . The institution of Dr. Ajroud-Driss has received research support from les Turner ALS Foundation. The institution of Dr. Ajroud-Driss has received research support from Hopewell. The institution of Dr. Ajroud-Driss has received research support from Peripheral neuropathy foundation. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
Lawrence E. Fried, MD Dr. Fried has received personal compensation for serving as an employee of Bayer Pharmaceuticals. Dr. Fried has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Virpax Pharmaceuticals. Dr. Fried has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Fried has stock in Bayer. Dr. Fried has stock in Horus. The institution of Dr. Fried has received research support from Health Resources & Services Administration of the United States Department of Health and Human Services.
Joseph Choi, MD Dr. Choi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Choi has received personal compensation in the range of $500-$4,999 for serving as a Case reviewer with Megellan Rx Management.
Itai Berger, MD Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Berger has received personal compensation in the range of $0-$499 for serving as a Consultant for Medison. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison.
Vikram Prakash, MD Dr. Prakash has nothing to disclose.
Silvia Bader-Weder, MD Dr. Bader-Weder has received personal compensation for serving as an employee of F. Hoffmann - La Roche. Dr. Bader-Weder has received stock or an ownership interest from F. Hoffmann - La Roche.
Ariel M. Lyons-Warren, MD, PhD Dr. Lyons-Warren has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. Dr. Lyons-Warren has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Paul Wuh-Liang Hwu Paul Wuh-Liang Hwu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics Inc.. Paul Wuh-Liang Hwu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. The institution of Paul Wuh-Liang Hwu has received research support from PTC therapeutics.
James R. Brasic, MD, FÂ鶹´«Ã½Ó³»­ Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Image Guided Therapy Research Institute. Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for One World, Inc.. Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Society of Nuclear Medicine and Molecular Imaging. Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multidisciplinary Digital Publishing Institute. Dr. Brasic has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Gerson Lehman Group, Inc..
Marissa P. DiGiovine, MD The institution of Dr. DiGiovine has received research support from HRSA.
Asia Payne, MD Ms. Payne has nothing to disclose.
Henry Houlden No disclosure on file
Yin-Hsiu Chien Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Avexis/Norvatis. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Yin-Hsiu Chien has received research support from Sanofi Genzyme.
Sylvia Mwanza-Kabaghe No disclosure on file
Ilse Peterson Ilse Peterson has received personal compensation for serving as an employee of Faegre Drinker Biddle & Reath.
Bradley Osterman, MD Dr. Osterman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Shire Pharma (Takeda). Dr. Osterman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for l'Institut national d'excellence en santé et en services sociaux .
Mattias Bischof, MD Dr. Bischof has received personal compensation for serving as an employee of Novartis Gene Therapy. Dr. Bischof has received stock or an ownership interest from Novartis Gene Therapy.
Lauren B. Elman, MD Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Elman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharamaceuticals. Dr. Elman has received publishing royalties from a publication relating to health care.
Mitchell Wilson, MD Dr. Wilson has nothing to disclose.
Sharon O. Wietstock, MD Dr. Wietstock has nothing to disclose.
Sanjeev V. Kothare, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kothare has nothing to disclose.
John P. Seibyl, MD Dr. Seibyl has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Invicro. Dr. Seibyl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Seibyl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Life Molecular Imaging. Dr. Seibyl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Seibyl has received stock or an ownership interest from Invicro.
Craig McDonald, MD Dr. McDonald has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Juan Piantino, MD Dr. Piantino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Cognition.
Thomas Sedlak Thomas Sedlak has nothing to disclose.
Niels V. Pacheco, MD Mr. Pacheco has nothing to disclose.
Tuba Rashid Khan, MD Dr. Rashid Khan has nothing to disclose.
Geoffrey K. Aguirre, MD, PhD Dr. Aguirre has received stock or an ownership interest from Nia therapeutics. The institution of Dr. Aguirre has received research support from Lion's Foundation. The institution of Dr. Aguirre has received research support from National Institutes of Health. The institution of Dr. Aguirre has received research support from Johnson and Johnson. The institution of Dr. Aguirre has received research support from Department of Defense.
Dejan Budimirovic No disclosure on file
Monique M. Ryan, MD Dr. Ryan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Ryan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen . The institution of Dr. Ryan has received research support from Save our Sons Muscular Dystrophy . The institution of Dr. Ryan has received research support from Muscular Dystrophy Australia. Dr. Ryan has received publishing royalties from a publication relating to health care.
Nassim Rad, MD Dr. Rad has nothing to disclose.
Nitish Chourasia, MD Dr. Chourasia has nothing to disclose.
Robert F. Lopez-Alberola, MD Dr. Lopez-Alberola has nothing to disclose.
Rea Mittal, MD Miss Mittal has nothing to disclose.
Chad R. Heatwole, MD, FÂ鶹´«Ã½Ó³»­ Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Virginia Commonwealth University. Dr. Heatwole has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Legal Med. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $0-$499 for serving as a Consultant for Iris. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Recursion. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for New York Central Mutual. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Penn Prop and Gas. The institution of Dr. Heatwole has received research support from Department of Defense. The institution of Dr. Heatwole has received research support from Novartis. The institution of Dr. Heatwole has received research support from MJFF. The institution of Dr. Heatwole has received research support from FARA. The institution of Dr. Heatwole has received research support from NIH. The institution of Dr. Heatwole has received research support from University of Miami. The institution of Dr. Heatwole has received research support from MDA. Dr. Heatwole has received intellectual property interests from a discovery or technology relating to health care.
Edward J. Fine, MD, FÂ鶹´«Ã½Ó³»­ Dr. Fine has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Friends of PALS (People with ALS.
Michael Potchen Michael Potchen has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Jackson & Campbell, P.C.. Michael Potchen has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rotezel & Andress.
David Michelson, MD Dr. Michelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Michelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OptumRx. The institution of Dr. Michelson has received research support from UCB SA. The institution of Dr. Michelson has received research support from Teva Pharmaceuticals USA. The institution of Dr. Michelson has received research support from PTC Therapeutics, Inc. The institution of Dr. Michelson has received research support from Novartis. The institution of Dr. Michelson has received research support from Biogen, Inc. Dr. Michelson has received publishing royalties from a publication relating to health care.
Angela Dodman Angela Dodman has received personal compensation for serving as an employee of F. Hoffman-La Roche Ltd.
Jimmy Holder, MD Dr. Holder has received personal compensation in the range of $0-$499 for serving as a Consultant with Stoke Pharmaceutical.
Tiffani McDonough, MD Dr. McDonough has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for PA Law Firm.
MaryLynn Chu, MD Dr. Chu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics; PTC Therapeutics,Inc..
Nicholas S. Abend, MD, FÂ鶹´«Ã½Ó³»­ Dr. Abend has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Epilepsy Foundation. The institution of Dr. Abend has received research support from NIH. The institution of Dr. Abend has received research support from PCORI. Dr. Abend has received publishing royalties from a publication relating to health care.
Donya Eizadkhah, MD Dr. Eizadkhah has nothing to disclose.
Sonya G. Wang, MD Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Therapeutics.
Gretchen L. Birbeck, MD, MPH, DTMH, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Tahseen Mozaffar, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Camille S. Corre, MD Dr. Corre has nothing to disclose.
Liana Theroux, MD Dr. Theroux has nothing to disclose.
Barbra Giourgas, MD Dr. Giourgas has nothing to disclose.
Vinay Penematsa Vinay Penematsa has nothing to disclose.
Alexander Lossos, MD Dr. Lossos has nothing to disclose.
Mary A. Bailey, MD Dr. Bailey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Bailey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers Squibb. Dr. Bailey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bailey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyne. Dr. Bailey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bailey has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Bailey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Bailey has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Bailey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genzyme. Dr. Bailey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Bailey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Bailey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Celgene. Dr. Bailey has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Meyers Squibb.
Joanna I. Garcia Pierce, MD Dr. Garcia Pierce has nothing to disclose.
Giulia Longoni, MD Dr. Longoni has nothing to disclose.
Melissa Hutchinson, MD Dr. Hutchinson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Katz, Korin, Cunningham Attorneys At Law.
E. Ann Yeh, MD, MA, FRCPC Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Terry D. Heiman-Patterson, MD Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Gabrielle Doré-Brabant Gabrielle Doré-Brabant has nothing to disclose.
Cherie Herren, MD Dr. Herren has nothing to disclose.
Claudio Bruno Claudio Bruno has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Claudio Bruno has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Claudio Bruno has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
Esau G. Mbewe Esau G. Mbewe has received research support from Research was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number K23NS117310. .
Marina Kushnirsky, MD Dr. Kushnirsky has nothing to disclose.
Dustin L. Gable, MD, PhD Dr. Gable has nothing to disclose.
Danielle A. Nolan, MD Dr. Nolan has received personal compensation in the range of $0-$499 for serving as a Consultant for Greenwich Biosciences.
Kimberly Goodspeed, MD The institution of Dr. Goodspeed has received research support from Neurogene, Inc.
Basil T. Darras, MD The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Omar Dabbous Omar Dabbous has received personal compensation for serving as an employee of Novartis Gene Therapies. Omar Dabbous has received stock or an ownership interest from Novartis Gene Therapies.
Mary Curry, ND Mary Curry has received personal compensation for serving as an employee of Cure SMA.
Jorge Carranza, MD Dr. Carranza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IPSEN. Dr. Carranza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IPSEN.
Francesco Bibbiani, MD Dr. Bibbiani has nothing to disclose.
Carlyn Patterson Gentile, MD The institution of Dr. Patterson Gentile has received research support from NIH/NINDS. The institution of Dr. Patterson Gentile has received research support from Children's Hospital of Philadelphia. Dr. Patterson Gentile has received personal compensation in the range of $500-$4,999 for serving as a Faculty, Annual Scientific Meeting, Scottsdale Meeting with American Headache Society. Dr. Patterson Gentile has received personal compensation in the range of $5,000-$9,999 for serving as a Early Career Awardee with American Headache Society. Dr. Patterson Gentile has received personal compensation in the range of $0-$499 for serving as a Research Prize Awardee and travel expense coverage with NIH Pain Consortium. Dr. Patterson Gentile has received personal compensation in the range of $500-$4,999 for serving as a Faculty, Speaker with Headache Cooperative of New England. Dr. Patterson Gentile has received personal compensation in the range of $500-$4,999 for serving as a Speaker, Awardee with Â鶹´«Ã½Ó³»­.
Courtney Nguyen Courtney Nguyen has nothing to disclose.
Ingo Helbig, MD The institution of Dr. Helbig has received research support from NIH, German Research Foundation, The Hartwell Foundation, International League Against Epilepsy. Dr. Helbig has received intellectual property interests from a discovery or technology relating to health care.
Rachel Logan Rachel Logan has nothing to disclose.
Matthew Kirschen, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Kirschen has received research support from NIH.
Nusrat Ahsan, MD Dr. Ahsan has nothing to disclose.
Teri Schreiner, MD, MPH, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CDC. Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schreiner has received research support from Roche Genentech.
Jamie L. Palaganas, MD, FÂ鶹´«Ã½Ó³»­ Dr. Palaganas has nothing to disclose.
Alessandra Milesi-Halle, MD, PhD Dr. Milesi-Halle has nothing to disclose.
Margaux C. Masten, Undergraduate The institution of Miss Masten has received research support from Â鶹´«Ã½Ó³»­. The institution of Miss Masten has received research support from Neurogene. The institution of Miss Masten has received research support from Amicus. The institution of Miss Masten has received research support from Beyond Batten Disease Foundation. The institution of Miss Masten has received research support from NIH.
Christopher J. Yuskaitis, MD, PhD Dr. Yuskaitis has nothing to disclose.
Paulo Falabella No disclosure on file
Kristy Arbogast The institution of Kristy Arbogast has received research support from NIH. The institution of Kristy Arbogast has received research support from Pennsylvania Department of Health. The institution of Kristy Arbogast has received research support from Football Research Inc.
Olivia Tong, MD Dr. Tong has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Laurent Servais Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evox. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Shuang He No disclosure on file
Yash Shah, MD, MBBS, MPH Dr. Shah has nothing to disclose.
David Bearden, MD Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Bearden has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for law firms.
Sharon Stoll, DO Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for roche Genentech. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi/genzyme. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Stoll has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for alexion. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono . Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Stoll has stock in BeCare Link LLC. Dr. Stoll has stock in Global Consult MS .
Cynthia X. Wang, MD Dr. Wang has nothing to disclose.
Mark Pykett Mark Pykett has received personal compensation for serving as an employee of PTC Therapeutics. Mark Pykett has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for PTC Therapeutics. Mark Pykett has received stock or an ownership interest from PTC Therapeutics. Mark Pykett has received personal compensation in the range of $10,000-$49,999 for serving as a Observer with Pharming Group.
Patricia Musolino, MD, PhD An immediate family member of Dr. Musolino has received personal compensation for serving as an employee of EMD Sorono. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx Pharmaceuticals. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IONIS Pharmaceuticals . Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inozyme Pharma. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. An immediate family member of Dr. Musolino has or had stock in 2seventy Bio. An immediate family member of Dr. Musolino has or had stock in Editas Medicine. An immediate family member of Dr. Musolino has or had stock in Generation Bio. An immediate family member of Dr. Musolino has or had stock in Beam Therapeutics. An immediate family member of Dr. Musolino has or had stock in Ebotec . An immediate family member of Dr. Musolino has or had stock in Novonordisk. An immediate family member of Dr. Musolino has or had stock in Morphosys. The institution of Dr. Musolino has received research support from National Institute of Health-NINDS-R01. The institution of Dr. Musolino has received research support from Angea Biotherapeutics. The institution of Dr. Musolino has received research support from Minoryx Pharmaceuticals. The institution of Dr. Musolino has received research support from Belanger Foundation. The institution of Dr. Musolino has received research support from Rozwat Family Foundation. The institution of Dr. Musolino has received research support from Dooley Family Foundation. Dr. Musolino has received intellectual property interests from a discovery or technology relating to health care. Dr. Musolino has received publishing royalties from a publication relating to health care.
David J. Adams, MD Dr. Adams has nothing to disclose.
Loren A. McLendon, MD The institution of Dr. McLendon has received research support from LaRoche .
Catherine Stratton, MPH Miss Stratton has nothing to disclose.
Sama Astani, MD Dr. Astani has nothing to disclose.
Ksenija Gorni Dr. Gorni has received personal compensation for serving as an employee of Hoffman La Roche.
Karen Barlow, MD The institution of Dr. Barlow has received research support from Children's Hospital foundation. The institution of Dr. Barlow has received research support from Motor Accident Insurance Commission. The institution of Dr. Barlow has received research support from University of Queensland.
Michelle A. Farrar Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Michelle A. Farrar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Naila Makhani, MD Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Institute for Advanced Clinical Trials for Children. The institution of Dr. Makhani has received research support from NIH/NINDS. The institution of Dr. Makhani has received research support from Charles H Hood Foundation. The institution of Dr. Makhani has received research support from National Multiple Sclerosis Society. Dr. Makhani has received personal compensation in the range of $0-$499 for serving as a contributor to online content with WebMD. Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a contributor to a CME video podcast and newsletter with eMultiple Sclerosis Review. Dr. Makhani has received personal compensation in the range of $5,000-$9,999 for serving as a consultant with I-ACT for children.
Juliana Gurgel-Giannetti Juliana Gurgel-Giannetti has nothing to disclose.
Shafeeq Ladha, MD Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ladha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapa Therapeutics. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ladha has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Ladha has received research support from Biogen. The institution of Dr. Ladha has received research support from Sanofi. Dr. Ladha has received publishing royalties from a publication relating to health care.
Daniel Calame, MD, PhD Dr. Calame has nothing to disclose.
Reena Gogia Rastogi, MD Dr. Gogia Rastogi has received research support from PCORI. Dr. Gogia Rastogi has received personal compensation in the range of $500-$4,999 for serving as a speaker - First Contact program with American Headache Society.
Dirk Fischer The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann La Roche AG. The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann La Roche AG.
Stephanie Efthymiou Stephanie Efthymiou has nothing to disclose.
Anne Louise Oaklander, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Oaklander has received research support from National Institutes of Health.
Jacqueline Montes, PT, EdD, NCS Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Sara Molisani, MD Dr. Fridinger has nothing to disclose.
Nitya Beriwal, MBBS Dr. Beriwal has nothing to disclose.
Anne C. Van Cott, MD, FÂ鶹´«Ã½Ó³»­ Dr. Van Cott has nothing to disclose.
Erika F. Augustine, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Augustine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Augustine has received research support from NIH. The institution of Dr. Augustine has received research support from Beyond Batten Disease Foundation. Dr. Augustine has received publishing royalties from a publication relating to health care. Dr. Augustine has a non-compensated relationship as a Member, Board of Directors with American Brain Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Augustine has a non-compensated relationship as a Scientific Advisor with ARIA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Samuel J. Mackenzie, MD, PhD Dr. Mackenzie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phlow, Corp. Dr. Mackenzie has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Everyday Health, Inc. Dr. Mackenzie has received intellectual property interests from a discovery or technology relating to health care.
Allie C. Toth, MD Dr. Patterson has nothing to disclose.
Michael Kruer, MD Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC Therapeutics. The institution of Dr. Kruer has received research support from NIH NINDs. The institution of Dr. Kruer has received research support from Medtronic . Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NHRSA.
Angela L. Genge, MD Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Claudio Santos No disclosure on file
Jerry R. Mendell, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Mohammad N. Haider Mr. Haider has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Blink TBI. Mr. Haider has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Blink CNS. Mr. Haider has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oculogica Inc. Mr. Haider has stock in Headquarters Health. The institution of Mr. Haider has received research support from NIH. Mr. Haider has received research support from Headquarters Health. The institution of Mr. Haider has received research support from CDMRP/PRMRP.
John W. Day, MD, PhD Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PepGen. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epirium Bio. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Astellas Pharma. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. The institution of Dr. Day has received research support from AMO Pharma. The institution of Dr. Day has received research support from AnnJi. Dr. Day has received research support from CureSMA. The institution of Dr. Day has received research support from Muscular Dystrophy Association. The institution of Dr. Day has received research support from Ionis Pharmaceuticals. The institution of Dr. Day has received research support from NMD Pharma. The institution of Dr. Day has received research support from SMA Foundation. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Edmar Zanoteli Edmar Zanoteli has nothing to disclose.
Ann H. Tilton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date.
Andrea J. Bartels, NP Ms. Bartels has nothing to disclose.
Renata Scalco, MD No disclosure on file
M E. McCormick, DO Dr. McCormick has nothing to disclose.
Babitha Haridas, MBBS Dr. Haridas has nothing to disclose.
Hui Xiong No disclosure on file
Ana G. Cristancho, MD, PhD Dr. Cristancho has nothing to disclose.
Heather Adams The institution of Heather Adams has received research support from Current: NIH; Past: Abeona; Batten Research Alliance; American University Centers on Disabilities. An immediate family member of Heather Adams has received publishing royalties from a publication relating to health care. Heather Adams has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Critical Path Institute.
Susan T. Iannaccone, MD, FÂ鶹´«Ã½Ó³»­ Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. The institution of Dr. Iannaccone has received research support from AveXis. The institution of Dr. Iannaccone has received research support from Biogen. The institution of Dr. Iannaccone has received research support from Sarepta. The institution of Dr. Iannaccone has received research support from PTC Therapeutics. The institution of Dr. Iannaccone has received research support from FibroGen. The institution of Dr. Iannaccone has received research support from ReveraGen. The institution of Dr. Iannaccone has received research support from MDA. The institution of Dr. Iannaccone has received research support from PPMD. The institution of Dr. Iannaccone has received research support from NIH. Dr. Iannaccone has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
Nathan Bachtell, MD Dr. BACHTELL has received personal compensation for serving as an employee of Symic Bio. Dr. BACHTELL has received personal compensation for serving as an employee of Audentes.
Hsiao-Tuan Chao, MD An immediate family member of Dr. Chao has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Capsida. An immediate family member of Dr. Chao has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for COMBINEDBrain. Dr. Chao has received research support from NIH, Burroughs Wellcome Fund, the Pediatric Epilepsy Research Foundation, Cain Foundation for Epilepsy Research, the Robert and Janice McNair Foundation, and Texas Children's Hospital. An immediate family member of Dr. Chao has received intellectual property interests from a discovery or technology relating to health care.
Emer Oconnor, PhD Emer Oconnor has nothing to disclose.
Dawn Phillips Dawn Phillips has received personal compensation for serving as an employee of REGENXBIO. Dawn Phillips has stock in REGENXBIO.
Panayiota Trifillis Panayiota Trifillis has received personal compensation for serving as an employee of PTC Therapeutics. Panayiota Trifillis has received stock or an ownership interest from PTC Therapeutics, Inc.. Panayiota Trifillis has received intellectual property interests from a discovery or technology relating to health care.
Lydia Shenouda Lydia Shenouda has received personal compensation for serving as an employee of Novartis Gene Therapies. Lydia Shenouda has received stock or an ownership interest from Novartis Gene Therapies.
Christelle M. Achkar, MD Dr. Achkar has nothing to disclose.
Autumn S. Ivy, MD, PhD Dr. Ivy has nothing to disclose.
Mauricio R. Delgado, MD, FRCPC, FÂ鶹´«Ã½Ó³»­ Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv. The institution of Dr. Delgado has received research support from Ipsen.
Adam C. Kneepkens Mr. Kneepkens has nothing to disclose.
Saher Suleman, MD Dr. Suleman has nothing to disclose.
Lauren Morgenroth Ms. Morgenroth has received personal compensation for serving as an employee of TRiNDS. Ms. Morgenroth has stock in TRiNDS.
Deepti Chrusciel, MD Dr. Chrusciel has nothing to disclose.
Annapurna Poduri, MD, MPH An immediate family member of Dr. Poduri has received personal compensation for serving as an employee of Beam Therapeutics. An immediate family member of Dr. Poduri has stock in Beam Therapeutics. The institution of Dr. Poduri has received research support from NIH.
David M. Greer, MD, FÂ鶹´«Ã½Ó³»­ Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
James R. Lupski, MD, PhD Dr. Lupski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Lupski has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Genetics Center.
Angela Paradis Angela Paradis has received personal compensation for serving as an employee of Biogen. An immediate family member of Angela Paradis has received personal compensation for serving as an employee of Biogen. Angela Paradis has received stock or an ownership interest from Biogen. An immediate family member of Angela Paradis has received stock or an ownership interest from Biogen.
Jonathan W. Mink, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS.
Richard A. Able, Jr., PhD Dr. Able has received personal compensation for serving as an employee of Praxis Medicines. Dr. Able has received personal compensation for serving as an employee of PTC Therapeutics. Dr. Able has stock in Praxis Medicines. Dr. Able has received personal compensation in the range of $0-$499 for serving as a Employee with PTC therapeutics.
Crystal M. Proud, MD Dr. Proud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Proud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Proud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta. Dr. Proud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avexis. Dr. Proud has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Proud has received research support from Biogen. The institution of Dr. Proud has received research support from Sarepta. The institution of Dr. Proud has received research support from Avexis. The institution of Dr. Proud has received research support from PTC. The institution of Dr. Proud has received research support from CSL Behring. The institution of Dr. Proud has received research support from Scholar Rock. The institution of Dr. Proud has received research support from Catabasis.
Khosro Farhad, MD, FÂ鶹´«Ã½Ó³»­ Dr. Farhad has nothing to disclose.
Olivier Barret No disclosure on file
Beyza Ciftci Kavaklioglu, MD Dr. Ciftci Kavaklioglu has nothing to disclose.
Marisa S. Prelack, MD Dr. Prelack has nothing to disclose.
Peter Karachunski, MD Dr. Karachunski has nothing to disclose.
Fernando N. Galan, MD Dr. Galan has nothing to disclose.
Osman Farooq, MD Dr. Farooq has nothing to disclose.
Saima Kayani, MD Dr. Kayani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogene. The institution of Dr. Kayani has received research support from Neurogene. The institution of Dr. Kayani has received research support from NIH.
Michael Cartwright, MD Dr. Cartwright has received publishing royalties from a publication relating to health care.
Joel J. Jacob Mr. Jacob has nothing to disclose.
Max M. Klein, PhD The institution of Max M. Klein, PhD has received research support from NIH.
Clara Chow Haws, MD Dr. Chow Haws has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Chow Haws has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Chow Haws has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst.
Sitra Tauscher-Wisniewski Sitra Tauscher-Wisniewski has received personal compensation for serving as an employee of Novartis Gene Therapies.
Ricka Messer, MD The institution of Dr. Messer has received research support from Ultragenyx Pharmaceutical Inc. Dr. Messer has a non-compensated relationship as a Chair of the Pediatric Neurology Specialty Steering Board with Epic that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Messer has a non-compensated relationship as a Member of the Â鶹´«Ã½Ó³»­ Quality Informatics Subcommittee with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Ashutosh Kumar, MD Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC therapeutics. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Academy of Pediatrics. The institution of Dr. Kumar has received research support from PTC therapeutics. The institution of Dr. Kumar has received research support from Sarepta Therapeutics. The institution of Dr. Kumar has received research support from Novartis/Avexis. The institution of Dr. Kumar has received research support from Fibrogen . The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Genentech. The institution of Dr. Kumar has received research support from MDA. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Draft Report Reviewer/consultant with ECRI/Atheneum/QTC commercial services LLC/Connected Research and consulting/Vox.Bio.
Sonal O. Bhatia, MD Dr. Bhatia has nothing to disclose.
Cheryl Wong Po Foo Cheryl Wong Po Foo has nothing to disclose.
Claudia A. Chiriboga, MD, FÂ鶹´«Ã½Ó³»­ Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Chiriboga has received research support from Roche. The institution of Dr. Chiriboga has received research support from Avexis/Novartis. The institution of Dr. Chiriboga has received research support from Biogen. The institution of Dr. Chiriboga has received research support from NIH. The institution of Dr. Chiriboga has received research support from Biohaven. The institution of Dr. Chiriboga has received research support from Genentec. Dr. Chiriboga has received publishing royalties from a publication relating to health care.
Gayatra Mainali, MD Dr. Mainali has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Origin Biosciences.
Paul Harmatz Paul Harmatz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BioMarin. Paul Harmatz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SOBI. Paul Harmatz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chiesi. Paul Harmatz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inventiva. Paul Harmatz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Paradigm. Paul Harmatz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for JCR. Paul Harmatz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Denali. Paul Harmatz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Homology. Paul Harmatz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Enzyvant. Paul Harmatz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Audentis. Paul Harmatz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aeglea. Paul Harmatz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeglea. The institution of Paul Harmatz has received research support from BioMarin.
Claudio M. De Gusmao, MD Dr. DeGusmao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mendelics Genomic Analysis. Dr. DeGusmao has received personal compensation in the range of $0-$499 for serving as a Consultant for EBSCO publishing. Dr. DeGusmao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Outcome Solutions. Dr. DeGusmao has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC Therapeuthics. The institution of Dr. DeGusmao has received research support from FDA.
Grace A. Zimmerman, MPH The institution of Ms. Zimmerman has received research support from National Institutes of Health. The institution of Ms. Zimmerman has received research support from Batten Disease Support and Research Association. The institution of Ms. Zimmerman has received research support from Greater Rochester Health Foundation.
Lisa Belter Lisa Belter has received personal compensation for serving as an employee of Cure SMA.
Enrico S. Bertini, MD Dr. Bertini has received personal compensation for serving as an employee of Bambino Gesu' Children's Resesarch Hospital.
Hannah D. Smith Hannah Smith has nothing to disclose.
Umesh D. Kalane, MD Dr. Kalane has nothing to disclose.
Margaret R. Frey, DO Dr. Frey has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biogen. Dr. Frey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Frey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Frey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Kayoko Saito No disclosure on file
Naveen Sankhyan, MD, MBBS, DM The institution of Dr. Sankhyan has received research support from PTC Therapeutics for a Multicentric RCT. Dr. Sankhyan has received research support from Institute Grant, PGIMER, (Goverment Entity).
Tom Parry Tom Parry has received personal compensation for serving as an employee of Ovid Therapeutics Inc. Tom Parry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingleheim. Tom Parry has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH.
Heidemarie Kletzl Heidemarie Kletzl has received personal compensation for serving as an employee of Hoffmann-La Roche.
Nicolas Chrestian, MD Dr. Chrestian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Chrestian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Chrestian has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Peer choice.
Danna L. Jennings, MD Dr. Jennings has received personal compensation for serving as an employee of Denali Therapeutics . Dr. Jennings has received stock or an ownership interest from Denali Therapeutics.
Daniel L. Kenney-Jung, MD The institution of Dr. Kenney-Jung has received research support from CFC Foundation. The institution of Dr. Kenney-Jung has received research support from Advanced Medical Electronics/NIH. The institution of Dr. Kenney-Jung has received research support from Bluebird Bio. The institution of Dr. Kenney-Jung has received research support from Rare Disease Foundation.
Jennifer A. Vermilion, MD The institution of Dr. Vermilion has received research support from Centers for Disease Control. The institution of Dr. Vermilion has received research support from Emalex Biosciences. The institution of Dr. Vermilion has received research support from Biomarin. The institution of Dr. Vermilion has received research support from Neurogene, Inc. Dr. Vermilion has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Tourette Association of America. Dr. Vermilion has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Centers for Disease Control and Prevention and American Academy of Pediatrics.
Francesco Muntoni, MD Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
William S. David, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. David has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dysimmune Disorders foundation. Dr. David has received publishing royalties from a publication relating to health care.
Mark Andrews Mark Andrews has nothing to disclose.
Tina Duong Tina Duong has received personal compensation for serving as an employee of Roche. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Scholar Rock. Tina Duong has received personal compensation for serving as an employee of Genentech. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Sarepta. Tina Duong has received personal compensation for serving as an employee of Biogen. Tina Duong has received personal compensation for serving as an employee of Audentes. Tina Duong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tina Duong has received personal compensation in the range of $0-$499 for serving as a Consultant for Audentes. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Tina Duong has received research support from biogen. The institution of Tina Duong has received research support from scholar rock.
Paul Orchard No disclosure on file
Florian Eichler, MD An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Manan Nath, MBBS Dr. Nath has nothing to disclose.
Lindsey Vogt, MD Dr. Vogt has nothing to disclose.
Birgit Jaber No disclosure on file
Craig A. Press, MD, PhD Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Firms. Dr. Press has received research support from Marinus Pharmaceuticals. Dr. Press has received research support from Pediatric Epilepsy Research Foundation. Dr. Press has received research support from NIH.
Mary Chesshyre, MBBS Dr. Chesshyre has received personal compensation for serving as an employee of UCL Great Ormond Street Institute of Child Health.
Davut Pehlivan, MD Dr. Pehlivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals.
Nikaela Losievski Miss Losievski has nothing to disclose.
Kevin Strauss Kevin Strauss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis.
Nita Chen, MD Dr. Chen has nothing to disclose.
Meghan M. Branston, MD Dr. Branston has nothing to disclose.
Cole A. Deisseroth Cole Deisseroth has received personal compensation for serving as an employee of Baylor College of Medicine. Cole Deisseroth has received personal compensation in the range of $5,000-$9,999 for serving as a Student with Baylor College of Medicine Medical Scientist Training Program.
Madeleine Klein, BS The institution of an immediate family member of Madeleine Klein has received research support from NIH.
Amy Vierhile, NP, DNP Ms. Vierhile has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences.
Stephen J. Kolb, MD, PhD Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Perry Shieh, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
Uzma Sharif, MD Dr. Sharif has nothing to disclose.
Robert C. Stowe, MD Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences. Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kherkher Garcia, LLP.
Jason R. Thonhoff, MD Dr. Thonhoff has nothing to disclose.
Rosangel E. Cruz, MA Ms. Cruz has nothing to disclose.
Ryan Kammeyer, MD The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ogborn-Mihm Trial Lawyers. The institution of Dr. Kammeyer has received research support from Rocky Mountain Multiple Sclerosis Center.
Elyse Gadra Ms. Gadra has nothing to disclose.
Peggy C. Martinez Esteban, MD Dr. Martinez Esteban has nothing to disclose.
Padmavati R. Eksambe, MD Dr. Eksambe has nothing to disclose.
David S. Russell, MD, PhD Dr. Russell has received personal compensation for serving as an employee of Invicro. Dr. Russell has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. The institution of Dr. Russell has received research support from Biogen. The institution of Dr. Russell has received research support from Roche. The institution of Dr. Russell has received research support from Voyager. The institution of Dr. Russell has received research support from Eisai. The institution of Dr. Russell has received research support from Neuraly. The institution of Dr. Russell has received research support from Michael J. Fox Foundation. The institution of Dr. Russell has received research support from National Institutes for Health. The institution of Dr. Russell has received research support from Eli Lilly. The institution of Dr. Russell has received research support from Aprinoia.
Thomas O. Crawford, MD Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Katherine Muir, MD No disclosure on file
Elizabeth Harrison, MD Dr. Harrison has nothing to disclose.
Priyamvada Tatachar, MD Dr. Tatachar has nothing to disclose.
James N. Brenton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Brenton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. The institution of Dr. Brenton has received research support from NIH/NINDS. The institution of Dr. Brenton has received research support from Autoimmune Encephalitis Alliance. Dr. Brenton has received publishing royalties from a publication relating to health care. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA.
Daniel Lax, MD Dr. Lax has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Lax has received personal compensation in the range of $500-$4,999 for serving as a CME Lecturer with American Headache Society.
Andres Nascimento Osorio Andres Nascimento Osorio has nothing to disclose.
Carmen A. Aguirre Ms. Aguirre has nothing to disclose.
Mary L. Zupanc, MD, FÂ鶹´«Ã½Ó³»­ Dr. Zupanc has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Praxis . Dr. Zupanc has received personal compensation in the range of $500-$4,999 for serving as a Chair of Review Committee for potential TSC grants with Department of Defense --CDRMC and PRMRP. Dr. Zupanc has a non-compensated relationship as a Board of Directors with Child Neurology Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Aaron M. McLaughlin, MD Dr. McLaughlin has nothing to disclose.
Laura Palfreeman No disclosure on file
Siddharth Srivastava, MD Dr. Srivastava has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuren. Dr. Srivastava has stock in NVDIA. Dr. Srivastava has stock in TSLA. Dr. Srivastava has stock in GOOGL. Dr. Srivastava has stock in AMZN. Dr. Srivastava has stock in NFLX. Dr. Srivastava has stock in MSFT. Dr. Srivastava has received personal compensation in the range of $500-$4,999 for serving as a DSMB Chair with Rush.
Keith Slifer The institution of Keith Slifer has received research support from National Heart, Lung, and Blood. Keith Slifer has received publishing royalties from a publication relating to health care.
Julie A. Parsons, MD Dr. Parsons has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenex. The institution of Dr. Parsons has received research support from AveXis. The institution of Dr. Parsons has received research support from Biogen. The institution of Dr. Parsons has received research support from Scholar Rock. The institution of Dr. Parsons has received research support from Biohaven. The institution of Dr. Parsons has received research support from PTC Therapeutics. The institution of Dr. Parsons has received research support from Novartis.
Laura A. Kirkpatrick, MD The institution of Dr. Kirkpatrick has received research support from American Epilepsy Society. The institution of Dr. Kirkpatrick has received research support from Child Neurologist Career Development Program. The institution of Dr. Kirkpatrick has received research support from Child Neurology Foundation. The institution of Dr. Kirkpatrick has received research support from Rosenau Family Research Foundation. The institution of Dr. Kirkpatrick has received research support from Society of Family Planning. The institution of Dr. Kirkpatrick has received research support from Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with One8 Foundation. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with Brigham and Women's Hospital. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Meeting Attendee with Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with Society of Family Planning. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Norton Children's Hospital. Dr. Kirkpatrick has a non-compensated relationship as a Board of Directors member with My Epilepsy Story that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Hugh J. McMillan, MD Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Gene Therapies. Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Gene Therapies. The institution of Dr. McMillan has received research support from Roche.
Brian Pfister Dr. Pfister has received personal compensation for serving as an employee of Praxis Precisions Medicines. Dr. Pfister has stock in Praxis Precision Medicines.
Richard S. Finkel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Kathryn J. Swoboda, MD Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Swoboda has received research support from Biogen.
Vinodh Narayanan, MD Dr. Narayanan has nothing to disclose.
Batool A. Hussain, MD, MBBS Dr. Hussain has nothing to disclose.
Katherine D. Mathews, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.